Constitutive class I-restricted exogenous presentation of self antigens in vivo - Wikidata - wikimedia - TriplyDB

Constitutive class I-restricted exogenous presentation of self antigens in vivo

Constitutive class I-restricted exogenous presentation of self antigens in vivo

http://www.wikidata.org/entity/Q36367249

about

Signalling through CD30 protects against autoimmune diabetes mediated by CD8 T cells Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease.Recombinant Newcastle disease virus as a vaccine vector for cancer therapy Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells The induction of tolerance by dendritic cells that have captured apoptotic cells DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8+ T cells in a spectrum of human MHC I haplotypes Dendritic cells: In the forefront of immunopathogenesis and vaccine development - A review Cross-Presentation of Cell-Associated Antigens by MHC Class I in Dendritic Cell Subsets Intracellular Transport Routes for MHC I and Their Relevance for Antigen Cross-Presentation Homeostasis and function of regulatory T cells (Tregs) in vivo: lessons from TCR-transgenic Tregs CCR4 promotes medullary entry and thymocyte-dendritic cell interactions required for central tolerance.Antigen recognition by autoreactive CD4⁺ thymocytes drives homeostasis of the thymic medulla Mouse Conventional Dendritic Cells Can be Universally Classified Based on the Mutually Exclusive Expression of XCR1 and SIRPα Macrophages present exogenous antigens by class I major histocompatibility complex molecules via a secretory pathway as a consequence of interferon-gamma activation Autoimmunity in MFG-E8-deficient mice is associated with altered trafficking and enhanced cross-presentation of apoptotic cell antigens How defects in central tolerance impinge on a deficiency in regulatory T cells Proteomic and metabolomic analyses of mitochondrial complex I-deficient mouse model generated by spontaneous B2 short interspersed nuclear element (SINE) insertion into NADH dehydrogenase (ubiquinone) Fe-S protein 4 (Ndufs4) gene Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes Self-tolerance to the murine homologue of a tyrosinase-derived melanoma antigen: implications for tumor immunotherapy Death pathways in T cell homeostasis and their role in autoimmune diabetes.Release of endogenous danger signals from HIFU-treated tumor cells and their stimulatory effects on APCs.Dynamic control of β1 integrin adhesion by the plexinD1-sema3E axis.Real-time immune cell interactions in target tissue during autoimmune-induced damage and graft tolerance.An evolving autoimmune microenvironment regulates the quality of effector T cell restimulation and function Cognate antigen engagement on parenchymal cells stimulates CD8+ T cell proliferation in situ.Enhancing the immunogenicity of exogenous hepatitis B surface antigen-based vaccines for MHC-I-restricted T cells.Activation-induced apoptosis of autoreactive and alloreactive T lymphocytes in the target organ as a major mechanism of tolerance.Tumor necrosis factor-alpha and the progression of diabetes in non-obese diabetic mice.CD30 prevents T-cell responses to non-lymphoid tissues.Role of dendritic cells in the induction and maintenance of autoimmune diseases.Role of autoreactive CD8+ T cells in organ-specific autoimmune diseases: insight from transgenic mouse models.Transgenes and knockout mutations in animal models of type 1 diabetes and multiple sclerosis.Evaluation of the therapeutic potential of bone marrow-derived myeloid suppressor cell (MDSC) adoptive transfer in mouse models of autoimmunity and allograft rejection.In vivo cyclophosphamide and IL-2 treatment impedes self-antigen-induced effector CD4 cell tolerization: implications for adoptive immunotherapy.Cutting edge: Extracellular signal-related kinase is not required for negative selection of developing T cells.The use of carboxyfluorescein diacetate succinimidyl ester to determine the site, duration and cell type responsible for antigen presentation in vivo.Cross-presentation of tumour antigens: evaluation of threshold, duration, distribution and regulation.Effector CD4 cells are tolerized upon exposure to parenchymal self-antigen.Herpes simplex virus type 1-specific cytotoxic T-lymphocyte arming occurs within lymph nodes draining the site of cutaneous infection Peripheral Tolerization of Effector and Memory T Cells: Implications for Autoimmunity and Tumor-Immunity.

P2860

Q22009150-B3DFABA1-E0FB-43F4-B03E-499E2C68BA28 Q24537348-8AE46838-95F3-4C96-AFB0-CD4088CDB3D1 Q24602728-E97F6ED6-0BEA-4F04-B625-CA7A356F5CE1 Q24653129-23AB96BE-6598-4218-920C-B47CCA9B7F75 Q24671078-6E494EB8-AEEE-495C-AF67-F1943B96642F Q24682603-89C48D51-A4DC-48DC-AED4-5B07D6EA736F Q24792153-4DC1C837-DECF-4F93-8A2B-EC29DF5C80FA Q26799991-F7D72871-F2FF-4FAD-A703-F7E2E3DC0ED6 Q26801963-1686A39E-8500-477B-8544-898CC7FB9FA4 Q26853599-A5211F6C-C250-44C3-BE43-ABC9D0D5D34B Q27308795-6FC8D0B8-5F91-4A91-9D02-EAB7E3D7F2CE Q27324446-DD4712D1-630A-49F3-ACEA-B44BC6812ACC Q28084718-7F032FE2-BFA7-4A73-AE0D-DF3EB3D09944 Q28366007-08784758-9832-41E5-8310-C3AB90B8DFA5 Q28388910-A8C025A0-8046-4F87-83ED-31621AC888CC Q28511833-457A260F-9A8D-4132-9955-D5777D486C4B Q28579972-52317E6B-2EB9-4437-8BC5-87338E443768 Q28609747-0A03828D-33DB-44D9-B069-57E6DBFC50FF Q30305530-30723332-5643-43BD-935E-1425C7C84787 Q30443591-B365A64F-AD65-44FE-A12F-AEB9361D77C8 Q30501320-31A5956B-3FE0-421D-9FE4-91F98BCCA75B Q30564304-5B200AFF-F5B1-4C69-B0DE-C921241A4BAD Q30573918-A936F2EC-D8BE-4EE2-A39E-045B04E3855F Q30582456-BC05E87B-3A36-4353-944E-7424FD97DF7E Q33571993-29DF7822-31D8-40F5-BDA0-CCF18EA5094F Q33605386-9D479466-C0BE-4FDC-9D45-E55FB15C2213 Q33653449-7EA8934F-5EA3-4D1B-80A6-3539852A2C0E Q33713257-E69EE6A9-5C94-4AF8-9703-F652A0ABF80B Q33713263-5FD6BD6B-B0E0-4678-B650-713F652E6946 Q33713274-5932AE37-27D3-4341-A8BA-5C6265D8481E Q33713291-2A3DDCBE-E5FB-4E8A-884A-DB7A51A0810D Q33713298-07C22152-0C30-4B8A-888A-E7A1F3240470 Q33754157-507E2E4F-7093-44B5-A73D-C21099C2EDC6 Q33756565-9008D551-8F42-4D42-B2CD-399C9D339D90 Q33763027-1227D5F0-79BA-44C0-BDFC-F11B1DB763EB Q33778844-FE847256-E383-4E80-9AED-80C3F981DD6E Q33778847-B3396D13-C141-4B4D-8266-65C47F6F5101 Q33791198-D9492CCE-2E7C-44D5-BD16-BA6A4660C132 Q33799184-95E765E1-0CF6-4BE4-8034-C2C5A0099822 Q33801059-246D368B-DD0E-4201-AB76-5952B183DAE5

P2860

Constitutive class I-restricted exogenous presentation of self antigens in vivo

http://www.wikidata.org/entity/Q36367249

description

1996 nî lūn-bûn

@nan

1996年の論文

@ja

1996年学术文章

@wuu

1996年学术文章

@zh-cn

1996年学术文章

@zh-hans

1996年学术文章

@zh-my

1996年学术文章

@zh-sg

1996年學術文章

@yue

1996年學術文章

@zh

1996年學術文章

@zh-hant

name

Constitutive class I-restricted exogenous presentation of self antigens in vivo

@ast

Constitutive class I-restricted exogenous presentation of self antigens in vivo

@en

type

label

Constitutive class I-restricted exogenous presentation of self antigens in vivo

@ast

Constitutive class I-restricted exogenous presentation of self antigens in vivo

@en

prefLabel

Constitutive class I-restricted exogenous presentation of self antigens in vivo

@ast

Constitutive class I-restricted exogenous presentation of self antigens in vivo

@en

P1433

Q36367249-13BDC0F9-7800-4FFA-83A2-E8D58F70BCC9

P1476

Q36367249-A507B6DE-323C-49AA-8559-38E592621344

P2093

Q36367249-096288F2-2258-40F3-ADFE-A97320259C13

Q36367249-32D7BEF5-3952-4E74-924E-D7AAC3103FC4

Q36367249-39A3CA55-3DB8-4602-95CB-8F1AFDFC2F24

Q36367249-5135C59A-1198-444E-A4C2-6DB7FC0C3472

Q36367249-8BFC2002-8DEA-4FC8-BF82-229F955EF3AD

Q36367249-93F7583F-8CB5-46E3-AD18-83494E7D19D0

P2860

Q36367249-0A883F72-03C4-48C4-832C-BEEE3E413367

Q36367249-1012DED8-9B28-4B6A-B596-411A536E9E77

Q36367249-29F77A0B-DB1C-4F92-8ECB-9B7DCE943743

Q36367249-2CA626C4-36BE-4FFC-990D-E750DA6294A0

Q36367249-367DE0DD-F6CF-4FB7-8153-F9A2F7DC94A0

Q36367249-39493828-92D6-4921-ADA2-FA9C8D3EFA31

Q36367249-3976A870-FDAB-4668-84F9-7E862C858B1B

Q36367249-412D6084-E6D4-403E-9644-4E875AC84ED0

Q36367249-4AEEB137-8285-483E-BBC7-D3E005DB3061

Q36367249-4B9D6721-7A6D-443D-9CAF-6D073384A33E

P304

Q36367249-1B191307-8345-40DE-9889-A2E33EAE64F1

P31

Q36367249-0FABBF63-14F1-460C-876F-C4BAAB26537D

P356

Q36367249-D5AC762D-CE46-4424-82FB-8373A7EDD953

P407

Q36367249-87B4C84F-4CC2-4BE1-9510-9DB45C98C267

P433

Q36367249-055B7444-A0A5-4D81-8544-852DDA73C662

P478

Q36367249-3EE49ABC-F098-43C1-ABA2-3C182B63AE8B

P577

Q36367249-4DD90C55-E44C-4ED1-AB2B-1F8EF1D6257D

P5875

Q36367249-D22A4304-440B-46D0-AD70-A810C46D5F7D

P698

Q36367249-9419DBCB-36D5-48E6-92D3-42B297E26D79

P932

Q36367249-712A3A68-8CD2-4F78-B0C9-B50FD848F317

P356

P1433

Journal of Experimental Medicine

P1476

Constitutive class I-restricted exogenous presentation of self antigens in vivo

@en

P2093

C Kurts

http://www.w3.org/2001/XMLSchema#string

F R Carbone

http://www.w3.org/2001/XMLSchema#string

H Kosaka

http://www.w3.org/2001/XMLSchema#string

J Allison

http://www.w3.org/2001/XMLSchema#string

J F Miller

http://www.w3.org/2001/XMLSchema#string

W R Heath

http://www.w3.org/2001/XMLSchema#string

P2860

T cell receptor antagonist peptides induce positive selection

Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay.

Mast cells process bacterial Ags through a phagocytic route for class I MHC presentation to T cells.

Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens.

A new foreign policy: MHC class I molecules monitor the outside world.

Peripheral selection of the T cell repertoire.

Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages.

Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo.

The effect of allogeneic presensitization on H-Y graft survival and in vitro cell-mediated responses to H-y antigen.

Major histocompatibility complex class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocytosis.

P304

923-930

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.184.3.923

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

184

http://www.w3.org/2001/XMLSchema#string

P577

1996-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

14148427

http://www.w3.org/2001/XMLSchema#string

P698

9064352

http://www.w3.org/2001/XMLSchema#string

P932

2192761

http://www.w3.org/2001/XMLSchema#string